BIAF - bioAffinity Technologies, Inc.
1.03
0 0%
Share volume: 68,977
Last Updated: 03-05-2026
Business Services/Services – Research, Development, Testing Labs:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 11-14-2025 | |
| Total revenue | 2.406 M | 2.398 M | 2.350 M | 1.854 M | 1.446 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.406 M | 2.398 M | 2.350 M | 1.854 M | 1.446 M | |
| -0.36% | -1.97% | -21.14% | -21.99% | |||
| Operating expenses | 2.629 M | 2.927 M | 2.733 M | 2.958 M | 2.683 M | |
| Selling general and admin | 2.186 M | 2.473 M | 2.365 M | 2.453 M | 2.209 M | |
| Research and development | 442.599 K | 453.895 K | 368.202 K | 505.739 K | 473.900 K | |
| Total expenses | 4.352 M | 4.485 M | 4.324 M | 4.481 M | 3.739 M | |
| 3.08% | -3.59% | 3.62% | -16.56% | |||
| Operating income | -1.945 M | -2.088 M | -1.974 M | -2.627 M | -2.293 M | |
| Ebit | -1.958 M | -2.088 M | -1.979 M | -2.637 M | -5.044 M | |
| Pretax income | -1.958 M | -2.105 M | -1.998 M | -2.652 M | -5.048 M | |
| 7.49% | -5.06% | 32.70% | 90.36% | |||
| Income tax | 3.672 K | 5.419 K | 2.559 K | 8.695 K | 3.182 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.962 M | -2.110 M | -2.001 M | -2.660 M | -5.051 M | |
| -7.57% | 5.19% | -32.97% | -89.86% |